StemActiv brings hope for Stargardt disease

Home » Blog » Patient Story » StemActiv brings hope for Stargardt disease

This 19-year-old male patient suffers from Stargardt disease since childhood. His right eye vision declined dramatically in February 2021, due to fundus hemorrhage. Following are his OCT, FFA and ICGA images. Before StemActiv treatment, he could only see hand movement from the right eye. After the first VEGF treatment, his vision didn’t get change. His local doctor prescribed 6-months StemActiv and 3 times VEGF injections.

In September 2021, his right eye vision improved from hand movement to 0.3, he can manage his daily life independently and go back to college again.

Here is the link for ordering StemActiv :